Clearasil Rapid Rescue Deep Treatment Pads

Description

Clearasil® RAPID RESCUE DEEP TREATMENT PADS are formulated with salicylic acid as the active ingredient, providing maximum strength acne treatment. Each pad measures 2.19 inches (5.56 cm) in diameter and is designed for topical application. The product is packaged in a container containing 90 pads, offering a convenient solution for acne management. Clinical results indicate visible improvement in as little as 4 hours, with the formulation designed to start working instantly upon application.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of this product. The product should be applied by wiping a pad over the face and neck, ensuring that the entire affected area is covered with a thin layer.

Initial dosing should begin with one application daily. Depending on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily. It is important to monitor for excessive drying of the skin, which may necessitate a reduction in application frequency. If bothersome dryness or peeling occurs, the application should be adjusted to once a day or every other day to mitigate these effects.

Contraindications

There are no specified contraindications for this product. However, healthcare professionals should advise patients to discontinue use and consult a physician if skin or eye irritation develops.

Contact with the eyes should be avoided; in the event of exposure, the eyes must be rinsed thoroughly with water. The risk of skin irritation and dryness may increase if used concurrently with other topical acne medications; therefore, it is recommended to use only one topical acne medication at a time if irritation occurs. Additionally, the product should be limited to application on the face and neck.

Warnings and Precautions

This product is intended for external use only. It is flammable; therefore, it should be kept away from extreme heat or open flames to prevent any fire hazards.

Healthcare professionals should advise patients to avoid contact with the eyes. In the event of accidental exposure, it is crucial to rinse the eyes thoroughly with water. Skin irritation and dryness may be exacerbated if the product is used concurrently with other topical acne medications. To minimize the risk of irritation, it is recommended that patients limit the use of topical acne treatments to one product at a time.

The application of this product should be restricted to the face and neck areas only. Patients should be instructed to discontinue use and consult a healthcare provider if any skin or eye irritation develops.

It is essential to keep this product out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients using this product may experience various adverse reactions. Serious adverse reactions include skin or eye irritation, which necessitates discontinuation of use and consultation with a healthcare professional. Participants are advised to seek medical attention if such irritation develops.

Common adverse reactions associated with the use of this product include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of these reactions, it is recommended that patients limit the use of topical acne treatments to one at a time.

Warnings associated with this product indicate that it is for external use only and is flammable; therefore, it should be kept away from extreme heat or open flame. Patients should also avoid contact with the eyes, and in the event of contact, they should rinse thoroughly with water.

Additionally, this product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of additional topical agents is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Clearasil Rapid Rescue Deep Treatment Pads (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is recommended.

The product is intended for use limited to the face and neck. Due to the potential for excessive drying of the skin, it is advised to initiate treatment with one application daily. Dosage may be gradually increased to two or three times daily as needed or as directed by a healthcare professional.

If pediatric patients experience bothersome dryness or peeling, the frequency of application should be reduced to once a day or every other day.

Geriatric Use

Elderly patients may not have specific information regarding the use of Clearasil Rapid Rescue Deep Treatment Pads, including dosage adjustments, safety concerns, or special precautions. As such, healthcare providers should exercise caution when considering this treatment for geriatric patients.

Due to the absence of data on the safety and efficacy of this product in the elderly population, it is advisable to monitor these patients closely for any adverse effects or unexpected responses to treatment. Further clinical evaluation may be warranted to ensure appropriate management and care for elderly patients using this product.

Pregnancy

There is currently no information available regarding the use of Clearasil Rapid Rescue Deep Treatment Pads during pregnancy. This includes any safety concerns, dosage modifications, or special precautions that may be necessary for pregnant patients. Healthcare professionals should consider the lack of data when advising women of childbearing potential and weigh the potential risks and benefits before recommending this product during pregnancy.

Lactation

The safety of this product has not been established in lactating mothers. There is a potential for excretion in breast milk; therefore, caution should be exercised when using this product in nursing mothers.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Individuals are encouraged to report any adverse events to the designated phone number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children and to seek immediate medical assistance or contact a Poison Control Center if the product is swallowed.

Patients should be instructed to stop using the product and consult a doctor if they experience any skin or eye irritation. When using this product, it is important to avoid contact with the eyes; if the product does come into contact with the eyes, patients should rinse thoroughly with water.

Additionally, patients should be made aware that skin irritation and dryness may be more likely to occur if they are using another topical acne medication simultaneously. Therefore, it is recommended that they use only one topical acne medication at a time to minimize the risk of irritation. Finally, patients should limit the use of the product to the face and neck to ensure safe and effective application.

Storage and Handling

The product is supplied in a jar, and it is essential to keep the jar lid tightly closed to maintain its integrity. It should be stored in a cool, dry place, ensuring that it is not exposed to freezing temperatures. Additionally, it is important to note that the product should not be flushed down the toilet. Proper handling and storage conditions are crucial for preserving the quality and effectiveness of the product.

Additional Clinical Information

The product is administered topically, with patients instructed to apply a thin layer over the entire affected area of the face and neck one to three times daily. Clinicians should advise patients to avoid contact with the eyes; in the event of contact, thorough rinsing with water is recommended.

Patients may experience increased skin irritation and dryness if using another topical acne medication concurrently. It is advised to limit application to the face and neck, and to discontinue use and consult a doctor if skin or eye irritation develops. Should bothersome dryness or peeling occur, patients should reduce the frequency of application to once daily or every other day.

Drug Information (PDF)

This file contains official product information for Clearasil Rapid Rescue Deep Treatment Pads, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)